Posted on September 15, 2011
McLaren has today announced an interesting partnership with GlaxoSmithKline, one of the world’s leading phamaceuticals companies. The deal is all about McLaren applying know how and technology from years of perfecting the racing game to a corporate environment, such as GSK’s business. It’s something I’ve suggested for some time that F1 could usefully do for the outside world. The sport is all about innovating, adapting, overcoming, planning, reacting quickly, making strategic decisions and building a stable base. Pat Symonds once said that the attitude of the top engineers in F1 should be, “I don’t know how to do that, but More…
JA on F1 podcast
JA on F1 Connect
McLaren
Ferrari
Red Bull
Mercedes
Lotus
Williams
Sauber
Force India
Toro Rosso
Caterham
Marussia
JAF1 YouTube Channel
Sebastian Vettel
Fernando Alonso
Lewis Hamilton
Mark Webber Nico Rosberg
Jean-Eric Vergne Paul di Resta
Felipe Massa
Kimi Räikkönen Adrian Sutil Sebastian Vettel Fernando Alonso Kimi Räikkönen Lewis Hamilton Mark Webber Nico Rosberg Felipe Massa Paul di Resta Romain Grosjean Jenson Button Adrian Sutil Jean-Eric Vergne
Sergio Perez Daniel Ricciardo Nico Hulkenberg Esteban Gutierrez Valtteri Bottas
Pastor Maldonado Jules Bianchi Charles Pic Max Chilton
Giedo van der Garde
jQuery(function($){
$(".tweet").tweet({
join_text: "auto",
username: "jamesallenonf1",
avatar_size: 35,
count: 4,
auto_join_text_default: "",
auto_join_text_ed: "",
auto_join_text_ing: "",
auto_join_text_reply: "",
auto_join_text_url: "",
loading_text: "loading tweets..."
});
});
